Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
Logo Image
Feature|Videos|February 13, 2025 (Updated: March 4, 2025)

Lightship’s Approach to Accessible, Representative, and Impactful Clinical Trials

Author(s)Lightship

Sepehr Shojaei, VP of Design Solutions at Lightship, talks about how the company works with pharma and contract research organization (CRO) partners to support clinical trials that are patient-first and accessible.

Lightship prioritizes patient accessibility and centricity in clinical trials, ensuring a seamless and positive experience for every participant. Learn more about:

  • Lightship's mission and core purpose as a company
  • How Lightship’s mobile nursing teams and home visits enhance study participation and retention
  • The role of mobile research units in the community and how they enhance participant education, accessibility, and convenience

Related to this article

View more
Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.
Read more
© Grispb - © Grispb - stock.adobe.com
Comparing OpenAI and Mistral on Clinical Trial Matching
Mistral and OpenAI produced identical overall eligibility labels across 200 synthetic patient-study assessments, with criterion-level disagreements concentrated in inclusion criteria where models switch between “Uncertain” and “Not included” when records lack sufficient evidence, so model choice should be driven by deployment architecture, control, and cost rather than assumed interchangeability.
Read more
The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time
The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time
In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.
Read more